106 related articles for article (PubMed ID: 22791376)
1. A powerful yeast-based screening assay for the identification of inhibitors of indoleamine 2,3-dioxygenase.
Cerejo M; Andrade G; Roca C; Sousa J; Rodrigues C; Pinheiro R; Chatterjee S; Vieira H; Calado P
J Biomol Screen; 2012 Dec; 17(10):1362-71. PubMed ID: 22791376
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.
Vottero E; Balgi A; Woods K; Tugendreich S; Melese T; Andersen RJ; Mauk AG; Roberge M
Biotechnol J; 2006 Mar; 1(3):282-8. PubMed ID: 16897708
[TBL] [Abstract][Full Text] [Related]
3. S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Matsuno K; Takai K; Isaka Y; Unno Y; Sato M; Takikawa O; Asai A
Bioorg Med Chem Lett; 2010 Sep; 20(17):5126-9. PubMed ID: 20688518
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
[TBL] [Abstract][Full Text] [Related]
5. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
[TBL] [Abstract][Full Text] [Related]
6. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
[TBL] [Abstract][Full Text] [Related]
7. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
[TBL] [Abstract][Full Text] [Related]
8. Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Röhrig UF; Majjigapu SR; Chambon M; Bron S; Pilotte L; Colau D; Van den Eynde BJ; Turcatti G; Vogel P; Zoete V; Michielin O
Eur J Med Chem; 2014 Sep; 84():284-301. PubMed ID: 25036789
[TBL] [Abstract][Full Text] [Related]
9. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
12. Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
John S; Thangapandian S; Sakkiah S; Lee KW
Eur J Med Chem; 2010 Sep; 45(9):4004-12. PubMed ID: 20580138
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast.
Vottero E; Mitchell DA; Page MJ; MacGillivray RT; Sadowski IJ; Roberge M; Mauk AG
FEBS Lett; 2006 Apr; 580(9):2265-8. PubMed ID: 16574111
[TBL] [Abstract][Full Text] [Related]
14. A Novel High Throughput Virtual Screening Protocol to Discover New Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Xu H; Song Y; Yang Q
Chem Pharm Bull (Tokyo); 2017; 65(8):714-717. PubMed ID: 28768924
[TBL] [Abstract][Full Text] [Related]
15. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
[TBL] [Abstract][Full Text] [Related]
16. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
[TBL] [Abstract][Full Text] [Related]
17. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).
Dolušić E; Frédérick R
Expert Opin Ther Pat; 2013 Oct; 23(10):1367-81. PubMed ID: 23992582
[TBL] [Abstract][Full Text] [Related]
19. The evolution of three types of indoleamine 2,3 dioxygenases in fungi with distinct molecular and biochemical characteristics.
Yuasa HJ; Ball HJ
Gene; 2012 Aug; 504(1):64-74. PubMed ID: 22564706
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput screen to identify novel calcineurin inhibitors.
Margassery LM; Kennedy J; O'Gara F; Dobson AD; Morrissey JP
J Microbiol Methods; 2012 Jan; 88(1):63-6. PubMed ID: 22056231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
